Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Clément Tétaud"'
Autor:
Ahmad Chehaitly, Anne-Laure Guihot, Coralyne Proux, Linda Grimaud, Jade Aurrière, Benoit Legouriellec, Jordan Rivron, Emilie Vessieres, Clément Tétaud, Antonio Zorzano, Vincent Procaccio, Françoise Joubaud, Pascal Reynier, Guy Lenaers, Laurent Loufrani, Daniel Henrion
Publikováno v:
Antioxidants, Vol 11, Iss 6, p 1078 (2022)
Flow (shear stress)-mediated dilation (FMD) of resistance arteries is a rapid endothelial response involved in tissue perfusion. FMD is reduced early in cardiovascular diseases, generating a major risk factor for atherosclerosis. As alteration of mit
Externí odkaz:
https://doaj.org/article/402fcf77f57b4725b909c1e8af2aedf8
Autor:
Anne Clavreul, Emilie Roger, Milad Pourbaghi-Masouleh, Laurent Lemaire, Clément Tétaud, Philippe Menei
Publikováno v:
Drug Delivery, Vol 25, Iss 1, Pp 1756-1765 (2018)
Anticancer agents that target both tumor cells and angiogenesis are of potential interest for glioblastoma (GB) therapy. One such agent is sorafenib (SFN), a tyrosine kinase inhibitor. However, poor aqueous solubility and undesirable side effects lim
Externí odkaz:
https://doaj.org/article/9a7418f8f4d44aa482de42d70a3aa2b0
Autor:
Clément Tétaud, Emilie Roger, Laurent Lemaire, Philippe Menei, Anne Clavreul, Milad Pourbaghi-Masouleh
Publikováno v:
Drug Delivery
Drug Delivery, 2018, 25 (1), pp.1756-1765. ⟨10.1080/10717544.2018.1507061⟩
Drug Delivery, Taylor & Francis, 2018, 25 (1), pp.1756-1765. ⟨10.1080/10717544.2018.1507061⟩
Drug Delivery, Vol 25, Iss 1, Pp 1756-1765 (2018)
Drug Delivery, 2018, 25 (1), pp.1756-1765. ⟨10.1080/10717544.2018.1507061⟩
Drug Delivery, Taylor & Francis, 2018, 25 (1), pp.1756-1765. ⟨10.1080/10717544.2018.1507061⟩
Drug Delivery, Vol 25, Iss 1, Pp 1756-1765 (2018)
International audience; Anticancer agents that target both tumor cells and angiogenesis are of potential interest for glioblastoma (GB) therapy. One such agent is sorafenib (SFN), a tyrosine kinase inhibitor. However, poor aqueous solubility and unde
Autor:
Nicolas Lepareur, Olivier Couturier, Philippe Menei, Anne Clavreul, Djamel Dabli, Francis Bouchet, François Hindré, Audrey Rousseau, Laurent Lemaire, Annabelle Cikankowitz, Clément Tétaud, Emmanuel Garcion
Publikováno v:
Journal of Neuro-Oncology
Journal of Neuro-Oncology, Springer Verlag, 2017, 131 (1), pp.49-58. ⟨10.1007/s11060-016-2289-4⟩
Journal of Neuro-Oncology, 2017, 131 (1), pp.49-58. ⟨10.1007/s11060-016-2289-4⟩
Journal of Neuro-Oncology, Springer Verlag, 2017, 131 (1), pp.49-58. ⟨10.1007/s11060-016-2289-4⟩
Journal of Neuro-Oncology, 2017, 131 (1), pp.49-58. ⟨10.1007/s11060-016-2289-4⟩
International audience; Internal radiation strategies hold great promise for glioblastoma (GB) therapy. We previously developed a nanovectorized radiotherapy that consists of lipid nanocapsules loaded with a lipophilic complex of Rhenium-188 (LNC(188
Autor:
Hélène, Lajous, Raphaël, Riva, Bénédicte, Lelièvre, Clément, Tétaud, Sylvie, Avril, François, Hindré, Frank, Boury, Christine, Jérôme, Philippe, Lecomte, Emmanuel, Garcion
Publikováno v:
Biomaterials science. 6(9)
Glioblastoma is the most frequent and aggressive primary malignant tumor of the central nervous system with a gloomy prognosis. Platinum derivatives and one among them, cisplatin, exhibited promising results when locally administered into the brain o
Autor:
Clément Tétaud, Philippe Lecomte, Bénédicte Lelièvre, Christine Jérôme, Raphaël Riva, Hélène Lajous, Frank Boury, François Hindré, Emmanuel Garcion, Sylvie Avril
Publikováno v:
Biomaterials Science
Biomaterials Science, 2018, 6 (9), pp.2386-2409. ⟨10.1039/c8bm00346g⟩
Biomaterials Science, Royal Society of Chemistry (RSC), 2018, 6 (9), pp.2386-2409. ⟨10.1039/c8bm00346g⟩
Biomaterials Science, 2018, 6 (9), pp.2386-2409. ⟨10.1039/c8bm00346g⟩
Biomaterials Science, Royal Society of Chemistry (RSC), 2018, 6 (9), pp.2386-2409. ⟨10.1039/c8bm00346g⟩
International audience; Glioblastoma is the most frequent and aggressive primary malignant tumor of the central nervous system with a gloomy prognosis. Platinum derivatives and one among them, cisplatin, exhibited promising results when locally admin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce9f3a6a1742bd35ea5d228a5f6c2a4
https://www.hal.inserm.fr/inserm-01959991/document
https://www.hal.inserm.fr/inserm-01959991/document
Autor:
Annabelle, Cikankowitz, Anne, Clavreul, Clément, Tétaud, Laurent, Lemaire, Audrey, Rousseau, Nicolas, Lepareur, Djamel, Dabli, Francis, Bouchet, Emmanuel, Garcion, Philippe, Menei, Olivier, Couturier, François, Hindré
Publikováno v:
Journal of neuro-oncology. 131(1)
Internal radiation strategies hold great promise for glioblastoma (GB) therapy. We previously developed a nanovectorized radiotherapy that consists of lipid nanocapsules loaded with a lipophilic complex of Rhenium-188 (LNC
Autor:
Nicolas Lepareur, François Hindré, O. Couturier, Emmanuel Garcion, F. Lacoeuille, A. Contini, Clément Tétaud
Publikováno v:
Médecine Nucléaire. 41:202-203
Introduction L’utilisation de nanocapsules lipidiques chargees en rhenium-188 (188Re-SSS-LNC) pour la radiotherapie interne vectorisee du glioblastome constitue une alternative innovante qui a presente des resultats prometteurs. Le systeme nanocaps
Autor:
Audrey Rousseau, Clément Tétaud, Amandine Etcheverry, Tony Avril, Jean Mosser, Philippe Menei, Cécile Henry, Anne Clavreul
Publikováno v:
Journal of Neuro-Oncology
Journal of Neuro-Oncology, 2015, 122 (1), pp.1-10. ⟨10.1007/s11060-014-1683-z⟩
Journal of Neuro-Oncology, Springer Verlag, 2015, 122 (1), pp.1-10. ⟨10.1007/s11060-014-1683-z⟩
Journal of Neuro-Oncology, 2015, 122 (1), pp.1-10. ⟨10.1007/s11060-014-1683-z⟩
Journal of Neuro-Oncology, Springer Verlag, 2015, 122 (1), pp.1-10. ⟨10.1007/s11060-014-1683-z⟩
International audience; Glioblastoma (GB) is a highly infiltrative tumor recurring within a few centimeters of the resection cavity in 90% of cases, even in cases of complete tumor resection and adjuvant chemo/radiotherapy. We recently isolated GB-as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::763cf957216655b69876466da3141e2e
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01117114
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01117114
Autor:
Anne-Laure Lainé, Claudia N. Montero-Menei, Florence Franconi, Philippe Menei, Clément Tétaud, Anne Clavreul, Catherine Passirani, Nolwenn Lautram, Angélique Montagu, Anne Vessières
Publikováno v:
International Journal of Nanomedicine
International Journal of Nanomedicine, Dove Medical Press, 2015, 10, pp.1259-71. ⟨10.2147/IJN.S69175⟩
International Journal of Nanomedicine, Dove Medical Press, 2015, 10, pp.1259-71. 〈10.2147/IJN.S69175〉
International Journal of Nanomedicine, 2015, 10, pp.1259-71. ⟨10.2147/IJN.S69175⟩
International Journal of Nanomedicine, Dove Medical Press, 2015, 10, pp.1259-71. ⟨10.2147/IJN.S69175⟩
International Journal of Nanomedicine, Dove Medical Press, 2015, 10, pp.1259-71. 〈10.2147/IJN.S69175〉
International Journal of Nanomedicine, 2015, 10, pp.1259-71. ⟨10.2147/IJN.S69175⟩
Anne Clavreul,1 Angélique Montagu,2 Anne-Laure Lainé,2 Clément Tétaud,2 Nolwenn Lautram,2 Florence Franconi,3 Catherine Passirani,2 Anne Vessières,4 Claudia N Montero-Menei,2 Philippe Menei1 1Département de Neurochirurgie, Centre Hospitalier Un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c7fb86da6ce4c5d4ff7052b2dda36c7
https://hal.archives-ouvertes.fr/hal-01392451
https://hal.archives-ouvertes.fr/hal-01392451